Table of Contents

company-logo

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Inozyme Pharma Dividend Announcement

• Inozyme Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Inozyme Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Inozyme Pharma Dividend History

Inozyme Pharma Dividend Yield

Inozyme Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Inozyme Pharma stock? Use our calculator to estimate your expected dividend yield:

Inozyme Pharma Financial Ratios

P/E ratio-2.62
PEG ratio0.21
P/B ratio3.06
ROE-88.42%
Payout ratio0.00%
Current ratio7.68
Quick ratio7.68
Cash Ratio1.34

Inozyme Pharma Dividend FAQ

Does Inozyme Pharma stock pay dividends?
Inozyme Pharma does not currently pay dividends to its shareholders.
Has Inozyme Pharma ever paid a dividend?
No, Inozyme Pharma has no a history of paying dividends to its shareholders. Inozyme Pharma is not known for its dividend payments.
Why doesn't Inozyme Pharma pay dividends?
There are several potential reasons why Inozyme Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Inozyme Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Inozyme Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Inozyme Pharma a dividend aristocrat?
Inozyme Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Inozyme Pharma a dividend king?
Inozyme Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Inozyme Pharma a dividend stock?
No, Inozyme Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Inozyme Pharma stocks?
To buy Inozyme Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Inozyme Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.